- Syros Pharmaceuticals ( NASDAQ: SYRS ) is scheduled to announce Q3 earnings results on Monday, November 14th, before market open.
- The consensus EPS Estimate is -$3.83 and the consensus Revenue Estimate is $5.18M (-9.1% Y/Y).
- Over the last 2 years, SYRS has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 1 downward.
For further details see:
Syros Pharmaceuticals Q3 2022 Earnings Preview